Joshua Tree spider species named for U2′s Bono






JOSHUA TREE NATIONAL PARK, Calif. (AP) — It appeared Bono and arachnids didn’t mix when his “Spider-Man” musical had a rough Broadway run, but that didn’t keep a biologist from naming an actual spider species after the U2 singer.


Jason Bond of Alabama’s Auburn University has identified 33 new species of trapdoor spider, including three of them in the California desert at Joshua Tree National Park. The park’s namesake is featured in the title and cover of U2′s 1987 album, “The Joshua Tree.”






The Riverside Press-Enterprise (http://bit.ly/UWsRjW ) reports that Bond named two of the spiders after Indian tribes and one, A. bonoi, after Bono.


Bond has named other spider species after Angelina Jolie, Cesar Chavez and Stephen Colbert.


The trapdoor spider, found in the Southwestern U.S., is so-named because it makes a hatch to hide from prey.


___


Information from: The Press-Enterprise, http://www.pe.com


Entertainment News Headlines – Yahoo! News





Title Post: Joshua Tree spider species named for U2′s Bono
Url Post: http://www.news.fluser.com/joshua-tree-spider-species-named-for-u2s-bono/
Link To Post : Joshua Tree spider species named for U2′s Bono
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Lilly drug chosen for Alzheimer's prevention study


Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study testing whether it's possible to prevent Alzheimer's disease in older people at high risk of developing it.


The drug, called solanezumab (sol-ah-NAYZ-uh-mab), is designed to bind to and help clear the sticky deposits that clog patients' brains.


Earlier studies found it did not help people with moderate to severe Alzheimer's but it showed some promise against milder disease. Researchers think it might work better if given before symptoms start.


"The hope is we can catch people before they decline," which can come 10 years or more after plaques first show up in the brain, said Dr. Reisa Sperling, director of the Alzheimer's center at Brigham and Women's Hospital in Boston.


She will help lead the new study, which will involve 1,000 people ages 70 to 85 whose brain scans show plaque buildup but who do not yet have any symptoms of dementia. They will get monthly infusions of solanezumab or a dummy drug for three years. The main goal will be slowing the rate of cognitive decline. The study will be done at 50 sites in the U.S. and possibly more in Canada, Australia and Europe, Sperling said.


In October, researchers said combined results from two studies of solanezumab suggested it might modestly slow mental decline, especially in patients with mild disease. Taken separately, the studies missed their main goals of significantly slowing the mind-robbing disease or improving activities of daily living.


Those results were not considered good enough to win the drug approval. So in December, Lilly said it would start another large study of it this year to try to confirm the hopeful results seen patients with mild disease. That is separate from the federal study Sperling will head.


About 35 million people worldwide have dementia, and Alzheimer's is the most common type. In the U.S., about 5 million have Alzheimer's. Current medicines such as Aricept and Namenda just temporarily ease symptoms. There is no known cure.


___


Online:


Alzheimer's info: http://www.alzheimers.gov


Alzheimer's Association: http://www.alz.org


___


Follow Marilynn Marchione's coverage at http://twitter.com/MMarchioneAP


Read More..

J.J. Abrams to produce Lance Armstrong biopic


LOS ANGELES (AP) — He's already gotten the Oprah treatment. Now Lance Armstrong is headed for the silver screen.


Paramount Pictures and J.J. Abrams' production company, Bad Robot, are planning a biopic about the disgraced cyclist, a studio spokeswoman said Friday.


They've secured the rights to New York Times reporter Juliet Macur's upcoming book "Cycle of Lies: The Fall of Lance Armstrong," due out in June. Macur covered the seven-time Tour de France winner for over a decade.


No director, writer, star or start date have been set.


Armstrong is in the midst of a two-part interview with Oprah Winfrey in which he admits to using performance-enhancing drugs to reach his historic victories, something he'd defiantly denied for years. The International Olympic Committee stripped him of his 2000 bronze medal this week.


Read More..

Chicago seeks investors for potential Midway Airport deal









Mayor Rahm Emanuel's administration on Friday began testing the investment market's appetite for a potential deal to privatize Midway Airport, launching the process for finding prospective bidders.


The city posted a "request for qualifications," seeking expressions of interest and documentation of credentials from teams interested in financing, operating, maintaining and improving the Southwest Side airport, which is the nation's 26th busiest, with about 9 million passengers passing through annually.


The document reiterates a framework, laid out by Emanuel earlier, aimed at providing city taxpayers with a better deal than the widely criticized 75-year agreement to privatize parking meter operations, carried out during former Mayor Richard Daley's administration. Proceeds from the earlier deal were used to plug operating deficits, and meter rates rose sharply.





This time, proposed leases must be less than 40 years, which locks in the city for a shorter period.


Rather than awarding the city only an upfront payment, the private operator also must share revenue with the city on an ongoing basis. Initial proceeds would be used to pay down debt issued since 1996 to rebuild the airport, the mayor's office said. There is about $1.4 billion in outstanding debt.


Longer term, cash flow would be directed to city infrastructure needs. The mayor has pledged proceeds would not be used to pay for city operations.


The city also is seeking assurances that prices for parking, food and beverages will be kept reasonable.


This is the second time Chicago has looked at privatizing Midway. A 99-year lease that would have brought in $2.5 billion died in 2009 when the financial markets froze up.


Prospective bidders will be asked to prove their ability to raise the needed financing, said Tom Alexander, a spokesman for the mayor.


As in the first go-round, the city is using Credit Suisse Securities LLC as its lead financial adviser.


"The city's process and approach will be thorough and open," Lois Scott, the city's chief financial officer, said in a written statement.


Southwest Airlines, the airport's dominant carrier, supports the move.


Some observers have said a structure with a shorter lease and greater control for the city could translate into lower bids.


But Alexander said the city was confident investors "would gladly meet our terms and still make very attractive offers." The city has declined to estimate how much such a deal could garner.


The request for proposal states "there is significant potential to increase commercial revenue both in terms of variety of activities and increases in sales per passenger."


The city posted the request for qualifications shortly after the Federal Aviation Administration accepted its preliminary application to privatize the airport, clearing the way for the city to move forward in its evaluation process.


Prospective bidders were asked to formally express their interest by Feb. 22. If the city moves forward and seeks proposals, a privatization plan could be submitted to the City Council this summer.


kbergen@tribune.com


Twitter @kathy_bergen





Read More..

Exhumation starts for lottery winner poisoned by cyanide









Several helicopters hovered over Rosehill Cemetery on Chicago's North Side this morning as police exhumed the body of a West Rogers Park man who died of cyanide poisoning last summer after winning a million-dollar lottery.


A hearse was being opened in front of a green tent set up at the grave site just north of Peterson Avenue and Urooj Khan's body was loaded into it. An evidence technician snapped a photo of it before the hearse's rear doors were closed up and the vehicle began driving away across the grass on the cemetery, escorted by a Chicago police evidence technician squad car and several other marked and unmarked police vehicles. They exited west onto Peterson Avenue.


The whole exhumation process lasted about two hours.





A medical examiner's office spokeswoman, Mary Paleologos, said if Khan's body is frozen, his autopsy will be performed at 7 a.m. Saturday. If not, the autopsy will be today. Paleologos also said Khan's body will be buried again on Monday.


A few medical examiner's office personnel were on hand for the exhumation, including Dr. Marta Helenowski, the forensic pathologist who originally handled Khan's case.


A backhoe and three or four pickup trucks were stationed at the grave site in the middle of the northern section of Rosehill earlier this morning, where a beam of light could be seen shining over Khan's headstone. The backhoe soon began its work digging into the ground at the grave site. In addition to the backhoe, one or two workers were seen helping dig up the body with shovels.


A large tent was set up at the site where some two dozen police officers were gathered. Among the officers are two Chicago police evidence technicians, Paleologos said. One was taking still photos of the exhumation, while the other was shooting video.


An unmarked police car and two blue barricades blocked off the Peterson Avenue gate to Rosehill, the only entrance and exit in the northern section of the cemetery.


Four TV trucks sat parked along the fence about 100 yards west of the grave site along Oakley Avenue, the designated staging area for the media. A group of about a dozen photographers, a videographer and TV reporters stood along the Peterson Avenue fence, next to where traffic moved along the busy thoroughfare like any normal morning rush hour.


A few passersby gazed at the police activity at the grave site from Oakley Avenue. One, curious about large presence inside the cemetery, was surprised to learned from a Tribune reporter that it was Khan's body being dug up. Another thought someone was having a funeral.


The exhumation of Khan's remains – scheduled to begin at about 7 a.m. – will come about six months after he was buried at Rosehill. In court papers last week, Chief Medical Examiner Stephen J. Cina said it was important to exhume the remains "as expeditiously as possible" since Khan's body was not embalmed.

In court papers, Cina said it was necessary to perform a full autopsy to "further confirm the results of the blood analysis as well as to rule out any other natural causes that might have contributed to or caused Mr. Khan's death."


A pathologist will take samples of Khan's stomach contents to try to determine how the cyanide was ingested, Mary Paleologos, Cina's spokeswoman, has said. They will also look at other organs such as the lungs to make certain the cyanide wasn't inhaled, she said.


The exhumation comes after the Tribune broke the story on Jan. 7 about Khan's mysterious death, sparking international media interest in the case.


The medical examiner's office initially ruled Khan's July 20 death was from hardening of the arteries when there were no signs of trauma on the body and a preliminary blood test didn't raise any questions. But the investigation was reopened about a week later after a relative suggested to authorities that Khan's death "may have been the result of poisoning," prosecutors said in a court filing seeking the exhumation.


The medical examiner's office contacted Chicago police Sept. 11 after tests showed cyanide in Khan's blood. By late November, more comprehensive toxicological tests showed lethal levels of the toxic chemical and the medical examiner's office declared his death a homicide.


Khan's widow, Shabana Ansari, who has hired a criminal-defense lawyer, told the Tribune last week that she had been questioned for more than four hours by detectives and had fully cooperated.  She said the detectives had asked her about ingredients she used to prepare his last meal of lamb curry, shared by Ansari, her father-in-law Fareedun Ansari and Khan's daughter from a previous marriage, Jasmeen, 17.


While a motive has not been determined, police have not ruled out that Khan was killed because of his lottery win, a law enforcement source has told the Tribune. He died before he could collect the winnings – a lump-sum payment of about $425,000 after taxes.


According to court records obtained by the Tribune, Khan's brother has squabbled with Shabana Ansari over the lottery winnings in probate court. The brother, ImTiaz Khan, raised concern that since Khan left no will, Jasmeen Khan would not get "her fair share" of her father's estate.


Khan and Ansari did not have children together. Since her father's death, Jasmeen Khan has been living with Khan's siblings.


An attorney for Ansari in the probate case said the money was all accounted for and the estate was in the process of being divided up by the court. Under state law, the estate typically would be split evenly between the spouse and Khan's only child, he said.


In addition, almost two years ago, the Internal Revenue Service placed liens on Khan's residence on West Pratt Boulevard in an effort to collect more than $120,000 in back taxes from his father-in-law,  Fareedun Ansari, who still lives at the home with his daughter.


Fareedun and Shabana Ansari have denied involvement in Khan's death.


jgorner@tribune.com

Twitter: @ChicagoBreaking





Read More..

Exclusive - Japan's Sharp curbs iPad screen output as Apple manages demand shift-sources


TOKYO/SEOUL (Reuters) - Sharp Corp has nearly halted production of 9.7-inch screens for Apple Inc's iPad, two sources said, as demand shifts to its smaller iPad mini.


Sharp's iPad screen production line at its Kameyama plant in central Japan has fallen to the minimal level to keep the line running this month after a gradual slowdown began at the end of 2012 as Apple manages its inventory, the industry sources with knowledge of Sharp's production plans told Reuters.


Sharp spokeswoman Miyuki Nakayama said: "We don't disclose production levels".


Apple officials, contacted late in the evening after normal business hours in California, did not have an immediate comment.


The sources didn't say how much of the slowdown was due to seasonal changes in demand or consumers opting for the smaller iPad mini and were unable to characterize Apple's overall tablet sales.


Macquarie Research has estimated that iPad shipments will tumble nearly 40 percent in the current quarter to about 8 million from about 13 million in the fourth quarter, although Apple's total tablet shipments will show a much smaller decrease due to strong iPad mini sales.


APPLE SHARES


Any indication that iPad sales are struggling could add to concern that the appeal of Apple products is waning after earlier media reports said it is slashing orders for iPhone 5 screens and other components from its Asian suppliers.


Those reports helped knock Apple's shares temporarily below $500 this week, the first time its stock had been below the threshold mark in almost one year.


Apple, the reports said, has asked state-managed Japan Display, Sharp and LG Display to halve supplies of iPhone panels from an initial plan for about 65 million screens in January-March. Apple is losing ground to Samsung, as well as emerging rivals including China's Huawei Technologies Co Ltd and ZTE Corp.


NO BIG CHANGE AT OTHER MAKERS


In addition to Sharp, Apple also buys iPad screens from LG Display Co Ltd, its biggest supplier, and Samsung Display, a flat-panel unit of Samsung Electronics.


Both LG Display and Samsung Display declined to comment.


A source at Samsung Display, however, said there had not been any significant change in its panel business with Apple, which has been steadily reducing panel purchases from the South Korean firm.


A person who is familiar with the situation at LG Display said iPad screen production in the current quarter had fallen from the previous quarter ending in December, mainly due to weak seasonal demand that is typical after the busy year-end holiday sales period.


Apple's iPad sales may have suffered amid a weak Christmas shopping period that hurt other consumer gadget makers as well.


CROWD OF RIVAL PRODUCTS


Apple also faces stiffening competition in tablets from a growing crowd of rival products from makers including Samsung with its Galaxy and Microsoft Corp's Surface. A consumer shift to smaller 7-inch screen devices, which Apple responded to late last year by launching its iPad mini for $329, are adding pressure.


BNP Paribas expects the iPad mini will eat into sales of the full-sized iPad, with the mini rise to 60 percent of total iPad shipments in the January-March quarter.


Looking to cut into Apple's market share in the smaller segment are Amazon.com Inc with its Kindle and Google Inc with its Nexus 7.


CEO, Tim Cook, who is credited with building Apple's Asian supply chain, has overseen several gadget launches, including the iPhone 5, the latest iPad models and the iPad mini during his first year, is under pressure to deliver the kind of product innovations that wowed consumers during Steve Jobs' tenure to keep his company's profit growth stellar.


Sharp, which also supplies screens for the iPhone, has been working with its main banks on a restructuring plan after posting a $5.6 billion loss for the past fiscal year. To secure emergency financing from lenders including Mizuho Financial Group and Mitsubishi Financial Group.it had mortgage its domestic factories and offices including the one building screens for Apple.


In December, Qualcomm Inc agreed to invest as much as $120 million in Sharp and the two companies said they would work to develop new power-saving screens.


(Additional reporting by Poornima Gupta in San Francisco; Writing by Tim Kelly; Editing by Ken Wills)



Read More..

IOC VP: Armstrong must tell 'whole truth'


LONDON (AP) — Lance Armstrong's doping confession to Oprah Winfrey was "too little, too late" and failed to provide any new information that will help clean up the sport he tarnished through years of cheating, the vice president of the IOC said Friday.


A day after stripping Armstrong of his bronze medal from the 2000 Sydney Olympics, the IOC urged the disgraced former Tour de France champion to supply details to anti-doping authorities in order to "bring an end to this dark episode."


In an interview with The Associated Press, IOC vice president Thomas Bach said Armstrong's admission to Winfrey that he used performance-enhancing drugs — after years of vehement denials —was not enough.


"If he thinks this interview would help him get credibility back, I think this is too little, too late," said Bach, a German lawyer who leads the IOC's anti-doping investigations. "It's a first step in the right direction, but no more.


"If he really loves his sport and wants to regain at least some credibility, then he should tell the whole truth and cooperate with the relevant sports bodies."


Armstrong is under pressure to come clean to the World Anti-Doping Agency, the U.S. Anti-Doping Agency and the independent commission set up the International Cycling Union.


"We have three sports bodies he can address," Bach said by telephone. "He needs to give testimony under oath. After lying for more than a dozen years, he needs to be questioned by experts and not just in a well-orchestrated interview."


In a statement from Lausanne, Switzerland, the IOC said: "We now urge Armstrong to present all the evidence he has to the appropriate anti-doping authorities so that we can bring an end to this dark episode and move forward, stronger and cleaner."


In the interview with Winfrey, Armstrong acknowledged that he used EPO, testosterone, human growth hormone and blood transfusions in order to win the Tour de France seven times.


"This is not enough," said Bach, who is a leading contender to succeed Jacques Rogge as IOC president in elections in September. "I hoped he would be more precise, that you would get an idea of who were the people behind him. He's even protected the famous Dr. Ferrari."


Bach was referring to Italian doctor Michele Ferrari, who worked closely with Armstrong and has been accused of being a mastermind of the cyclist's doping program.


"In some parts of the interview he was pretty evasive, in some parts contradicting himself," Bach said.


Bach said the interview offered no information beyond the USADA report that detailed widespread doping by Armstrong and his teammates and led to the stripping of his Tour titles and a lifetime ban from Olympic sports.


"We have no new facts — not a single new fact going beyond the USADA report," Bach said.


Armstrong denied in the interview that cycling body UCI covered up positive tests or helped him avoid detection.


Bach said the interview provided no allegations that would put cycling's Olympic status in jeopardy. Senior Canadian IOC member Dick Pound, a former head of WADA, suggested this week that cycling could be kicked out of the Olympics if there was proof of UCI collusion with Armstrong.


"I still hope for a full inquiry, but in general, you have to consider the anti-doping system since then has changed very much for the better," Bach said. "The UCI has introduced the blood passport, there is more target testing and out-of-competition testing and better methods for detecting EPO. You cannot draw conclusions from 10 years ago."


In Lausanne, the IOC said it "unreservedly condemns" the actions of Armstrong and all drug cheats.


"This is indeed a very sad day for sport but there is a positive side if these revelations can begin to draw a line under previous practices," the statement said. "It is the IOC's firm expectation that all parties involved will draw the necessary lessons from this case and continue to take all measures to ensure a level playing field for all athletes."


Read More..

Armstrong admits doping: ‘I’m a flawed character’






CHICAGO (AP) — He did it. He finally admitted it. Lance Armstrong doped.


He was light on the details and didn’t name names. He mused that he might not have been caught if not for his comeback in 2009. And he was certain his “fate was sealed” when longtime friend, training partner and trusted lieutenant George Hincapie, who was along for the ride on all seven of Armstrong’s Tour de France wins from 1999-2005, was forced to give him up to anti-doping authorities.






But right from the start and more than two dozen times during the first of a two-part interview Thursday night with Oprah Winfrey on her OWN network, the disgraced former cycling champion acknowledged what he had lied about repeatedly for years, and what had been one of the worst-kept secrets for the better part of a week: He was the ringleader of an elaborate doping scheme on a U.S. Postal Service team that swept him to the top of the podium at the Tour de France time after time.


“I’m a flawed character,” he said.


Did it feel wrong?


“No,” Armstrong replied. “Scary.”


“Did you feel bad about it?” Winfrey pressed him.


“No,” he said. “Even scarier.”


“Did you feel in any way that you were cheating?”


“No,” Armstrong paused. “Scariest.”


“I went and looked up the definition of cheat,” he added a moment later. “And the definition is to gain an advantage on a rival or foe. I didn’t view it that way. I viewed it as a level playing field.”


Wearing a blue blazer and open-neck shirt, Armstrong was direct and matter-of-fact, neither pained nor defensive. He looked straight ahead. There were no tears and very few laughs.


He dodged few questions and refused to implicate anyone else, even as he said it was humanly impossible to win seven straight Tours without doping.


“I’m not comfortable talking about other people,” Armstrong said. “I don’t want to accuse anybody.”


Whether his televised confession will help or hurt Armstrong’s bruised reputation and his already-tenuous defense in at least two pending lawsuits, and possibly a third, remains to be seen. Either way, a story that seemed too good to be true — cancer survivor returns to win one of sport’s most grueling events seven times in a row — was revealed to be just that.


“This story was so perfect for so long. It’s this myth, this perfect story, and it wasn’t true,” he said.


Winfrey got right to the point when the interview began, asking for yes-or-no answers to five questions.


Did Armstrong take banned substances? “Yes.”


Did that include the blood-booster EPO? “Yes.”


Did he do blood doping and use transfusions? “Yes.”


Did he use testosterone, cortisone and human growth hormone? “Yes.”


Did he take banned substances or blood dope in all his Tour wins? “Yes.”


In his climb to the top, Armstrong cast aside teammates who questioned his tactics, yet swore he raced clean and tried to silence anyone who said otherwise. Ruthless and rich enough to settle any score, no place seemed beyond his reach — courtrooms, the court of public opinion, even along the roads of his sport’s most prestigious race.


That relentless pursuit was one of the things that Armstrong said he regretted most.


“I deserve this,” he said twice.


“It’s a major flaw, and it’s a guy who expected to get whatever he wanted and to control every outcome. And it’s inexcusable. And when I say there are people who will hear this and never forgive me, I understand that. I do. …


“That defiance, that attitude, that arrogance, you cannot deny it.”


Armstrong said he started doping in mid-1990s but didn’t when he finished third in his comeback attempt.


Anti-doping officials have said nothing short of a confession under oath — “not talking to a talk-show host,” is how World Anti-Doping Agency director general David Howman put it — could prompt a reconsideration of Armstrong’s lifetime ban from sanctioned events.


He’s also had discussions with officials at the U.S. Anti-Doping Agency, whose 1,000-page report in October included testimony from nearly a dozen former teammates and led to stripping Armstrong of his Tour titles. Shortly after, he lost nearly all his endorsements, was forced to walk away from the Livestrong cancer charity he founded in 1997, and just this week was stripped of his bronze medal from the 2000 Olympics.


Armstrong could provide information that might get his ban reduced to eight years. By then, he would be 49. He returned to triathlons, where he began his professional career as a teenager, after retiring from cycling in 2011, and has told people he’s desperate to get back.


Initial reaction from anti-doping officials ranged from hostile to cool.


WADA president John Fahey derided Armstrong’s defense that he doped to create “a level playing field” as “a convenient way of justifying what he did — a fraud.”


“He was wrong, he cheated and there was no excuse for what he did,” Fahey said by telephone in Australia.


If Armstrong “was looking for redemption,” Fahey added, “he didn’t succeed in getting that.”


USADA chief Travis Tygart, who pursued the case against Armstrong when others had stopped, said the cyclist’s confession was just a start.


“Tonight, Lance Armstrong finally acknowledged that his cycling career was built on a powerful combination of doping and deceit,” Tygart said. “His admission that he doped throughout his career is a small step in the right direction. But if he is sincere in his desire to correct his past mistakes, he will testify under oath about the full extent of his doping activities.”


Livestrong issued a statement that said the charity was “disappointed by the news that Lance Armstrong misled people during and after his cycling career, including us.”


“Earlier this week, Lance apologized to our staff and we accepted his apology in order to move on and chart a strong, independent course,” it said.


The interview revealed very few details about Armstrong’s performance-enhancing regimen that would surprise anti-doping officials.


What he called “my cocktail” contained the steroid testosterone and the blood-booster erythropoetein, or EPO, “but not a lot,” Armstrong said. That was on top of blood-doping, which involved removing his own blood and weeks later re-injecting it into his system.


All of it was designed to build strength and endurance, but it became so routine that Armstrong described it as “like saying we have to have air in our tires or water in our bottles.”


“That was, in my view, part of the job,” he said.


Armstrong was evasive, or begged off entirely, when Winfrey tried to connect his use to others who aided or abetted the performance-enhancing scheme on the USPS team


When she asked him about Italian doctor Michele Ferrari, who was implicated in doping-related scrapes and has also been banned from cycling for life, Armstrong replied, “It’s hard to talk about some of these things and not mention names. There are people in this story, they’re good people and we’ve all made mistakes … they’re not monsters, not toxic and not evil, and I viewed Michele Ferrari as a good man and smart man and still do.”


But that’s nearly all Armstrong would say about the physician that some reports have suggested educated the cyclist about doping and looked after other aspects of his training program.


He was almost as reluctant to discuss claims by former teammates Tyler Hamilton and Floyd Landis that Armstrong told them, separately, that he tested positive during the 2001 Tour de Suisse and conspired with officials of the International Cycling Union officials to cover it up — in exchange for a donation.


“That story wasn’t true. There was no positive test, no paying off of the labs. There was no secret meeting with the lab director,” he said.


Winfrey pressed him again, asking if the money he donated wasn’t part of a tit-for-tat agreement, “Why make it?”


“Because they asked me to,” Armstrong began.


“This is impossible for me to answer and have anybody believe it,” he said. “It was not in exchange for any cover-up. … I have every incentive here to tell you yes.”


Finally, he summed up the entire episode this way: “I was retired. … They needed money.”


Ultimately, though, it was Landis who did the most damage to Armstrong’s story. Landis was stripped of the 2006 Tour title after testing positive and wound up on the sport’s fringes looking for work. Armstrong said his former teammate threatened to release potentially destructive videos if he wasn’t given a spot on the team. That was in 2009, when Armstrong returned to the Tour after four years off.


Winfrey asked whether Landis’ decision to talk was “the tipping point.”


“I’d agree with that. I might back it up a little and talk about the comeback. I think the comeback didn’t sit well with Floyd,” Armstrong recalled.


“Do you regret now coming back?”


“I do. We wouldn’t be sitting here if I didn’t come back,” he said.


The closest Armstrong came to contrition was when Winfrey asked him about his apologies in recent days, notably to former teammate Frankie Andreu, who struggled to find work in cycling after Armstrong dropped him from the USPS team, as well as his wife, Betsy. Armstrong said she was jealous of his success, and invented stories about his doping as part of a long-running vendetta.


“Have you made peace?” Winfrey asked.


“No,” Armstrong replied, “because they’ve been hurt too badly, and a 40-minute (phone) conversation isn’t enough.”


He also called London Sunday Times reporter David Walsh as well as Emma O’Reilly, who worked as a masseuse for the USPS team and later provided considerable material for a critical book Walsh wrote about Armstrong and his role in cycling’s doping culture.


Armstrong subsequently sued for libel in Britain and won a $ 500,000 judgment against the newspaper, which is now suing to get the money back. Armstrong was, if anything, even more vicious in the way he went after O’Reilly. He intimated she was let go from the Postal team because she seemed more interested in personal relationships than professional ones.


“What do you want to say about Emma O’Reilly?” Winfrey asked.


“She, she’s one of these people that I have to apologize to. She’s one of these people that got run over, got bullied.”


“You sued her?”


“To be honest, Oprah, we sued so many people I don’t even,” Armstrong said, then paused, “I’m sure we did.”


Near the end of the first interview installment, Winfrey asked about a federal investigation of Armstrong that was dropped by the Justice Department without charges.


“When they dropped the case, did you think: ‘Now, finally over, done, victory’?”


Armstrong looked up. He exhaled.


“It’s hard to define victory,” he said. “But I thought I was out of the woods.”


___


AP Sports Writers Jim Vertuno in Austin, Texas, Eddie Pells in Denver and Dennis Passa in Melbourne contributed to this report.


Entertainment News Headlines – Yahoo! News





Title Post: Armstrong admits doping: ‘I’m a flawed character’
Url Post: http://www.news.fluser.com/armstrong-admits-doping-im-a-flawed-character/
Link To Post : Armstrong admits doping: ‘I’m a flawed character’
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Food service vulnerable to food allergy lawsuits


WASHINGTON (AP) — People with severe food allergies have a new tool in their attempt to find menus that fit their diet: federal disabilities law. And that could leave schools, restaurants and anyplace else that serves food more vulnerable to legal challenges over food sensitivities.


A settlement stemming from a lack of gluten-free foods available to students at a Massachusetts university could serve as a precedent for people with other allergies or conditions, including peanut sensitivities or diabetes. Institutions and businesses subject to the Americans With Disabilities Act could be open to lawsuits if they fail to honor requests for accommodations by people with food allergies.


Colleges and universities are especially vulnerable because they know their students and often require them to eat on campus, Eve Hill of the Justice Department's civil rights division says. But a restaurant also could be liable if it blatantly ignored a customer's request for certain foods and caused that person to become ill, though that case might be harder to argue if the customer had just walked in off the street, Hill says.


The settlement with Lesley University, reached last month but drawing little attention, will require the Cambridge, Mass., institution to serve gluten-free foods and make other accommodations for students who have celiac disease. At least one student complained to the federal government after the school would not exempt the student from a meal plan even though the student couldn't eat the food.


"All colleges should heed this settlement and take steps to make accommodations," says Alice Bast, president and founder of the National Foundation for Celiac Awareness. "To our community this is definitely a precedent."


People who suffer from celiac disease don't absorb nutrients well and can get sick from the gluten found in wheat, rye and barley. The illness, which affects around 2 million Americans, causes abdominal pain, bloating and diarrhea, and people who have it can suffer weight loss, fatigue, rashes and other problems. Celiac is a diagnosed illness that is more severe than gluten sensitivity, which some people self-diagnose.


Ten years ago, most people had never heard of celiac disease. But awareness has exploded in recent years, for reasons that aren't entirely clear. Some researchers say it was under-diagnosed, others say it's because people eat more processed wheat products like pastas and baked goods than in past decades, and those items use types of wheat that have a higher gluten content.


Gluten-free diets have expanded beyond those with celiac disease. Millions of people are buying gluten-free foods because they say they make them feel better, even if they don't have a wheat allergy. Americans were expected to spend $7 billion on gluten-free foods last year.


With so many people suddenly concerned with gluten content, colleges and universities have had to make accommodations. Some will allow students to be exempted from meal plans, while others will work with students individually. They may need to do even more now as the federal government is watching.


"These kids don't want to be isolated," Bast says. "Part of the college experience is being social. If you can't even eat in the school cafeteria then you are missing out on a big part of college life."


Under the Justice Department agreement, Lesley University says it will not only provide gluten-free options in its dining hall but also allow students to pre-order, provide a dedicated space for storage and preparation to avoid cross-contamination, train staff about food allergies and pay a $50,000 cash settlement to the affected students.


"We are not saying what the general meal plan has to serve or not," Hill says. "We are saying that when a college has a mandatory meal plan they have to be prepared to make reasonable modifications to that meal plan to accommodate students with disabilities."


The agreement says that food allergies may constitute a disability under the Americans With Disabilities Act, if they are severe enough. The definition was made possible under 2009 amendments to the disability law that allowed for episodic impairments that substantially limit activity.


"By preventing people from eating, they are really preventing them from accessing their educational program," Hill says of the school and its students.


Mary Pat Lohse, the chief of staff and senior adviser to Lesley University's president, says the school has been working with the Justice Department for more than three years to address students' complaints. She says the school has already implemented most parts of the settlement and will continue to update policies to serve students who need gluten-free foods.


"The settlement agreement provides a positive road map for other colleges and universities to follow," Lohse says.


Joan Rector McGlockton of the National Restaurant Association says that restaurants have taken notice of an increasing demand for gluten free options, "drawing attention to the importance of providing these options as well as the preparation methods involved in serving these options."


The group has a training program for restaurants so they will know what to do when food allergy issues arise.


Some say the Justice Department decision goes too far. Hans von Spakovsky, a fellow at the conservative Heritage Foundation who worked in the civil rights division of the Justice Department under President George W. Bush, says food allergies shouldn't apply under the disability act. He adds that the costs could be substantial when schools are already battling backlash from high tuition costs.


"I certainly encourage colleges and universities to work with students on this issue, but the fact that this is a federal case and the Justice Department is going to be deciding what kind of meals could be served in a dining hall is just absurd," he says.


Whether the government is involved or not, schools and other food service establishments are likely to hear from those who want more gluten-free foods. Dhanu Thiyagarajan, a sophomore at the University of Pittsburgh, says she decided to speak up when she arrived at school and lost weight because there were too few gluten-free options available. Like Lesley University, the University of Pittsburgh requires that on-campus students participate in a meal plan.


Thiyagarajan eventually moved off campus so she could cook her own food, but not before starting an organization of students who suffer from wheat allergies like hers. She says she is now working with food service at the school and they have made a lot of progress, though not enough for her to move back on campus.


L. Scott Lissner, the disability coordinator at Ohio State University, says he has seen similar situations at his school, though people with food allergies have not traditionally thought of themselves as disabled. He says schools will eventually have to do more than just exempt students from a meal plan.


"This is an early decision on a growing wave of needs that universities are going to have to address," he says of the Lesley University agreement.


___


Follow Mary Clare Jalonick on Twitter at http://twitter.com/mcjalonick


Read More..

Armstrong admits doping: 'I'm a flawed character'


CHICAGO (AP) — He did it. He finally admitted it. Lance Armstrong doped.


He was light on the details and didn't name names. He mused that he might not have been caught if not for his comeback in 2009. And he was certain his "fate was sealed" when longtime friend, training partner and trusted lieutenant George Hincapie, who was along for the ride on all seven of Armstrong's Tour de France wins from 1999-2005, was forced to give him up to anti-doping authorities.


But right from the start and more than two dozen times during the first of a two-part interview Thursday night with Oprah Winfrey on her OWN network, the disgraced former cycling champion acknowledged what he had lied about repeatedly for years, and what had been one of the worst-kept secrets for the better part of a week: He was the ringleader of an elaborate doping scheme on a U.S. Postal Service team that swept him to the top of the podium at the Tour de France time after time.


"I'm a flawed character," he said.


Did it feel wrong?


"No," Armstrong replied. "Scary."


"Did you feel bad about it?" Winfrey pressed him.


"No," he said. "Even scarier."


"Did you feel in any way that you were cheating?"


"No," Armstrong paused. "Scariest."


"I went and looked up the definition of cheat," he added a moment later. "And the definition is to gain an advantage on a rival or foe. I didn't view it that way. I viewed it as a level playing field."


Wearing a blue blazer and open-neck shirt, Armstrong was direct and matter-of-fact, neither pained nor defensive. He looked straight ahead. There were no tears and very few laughs.


He dodged few questions and refused to implicate anyone else, even as he said it was humanly impossible to win seven straight Tours without doping.


"I'm not comfortable talking about other people," Armstrong said. "I don't want to accuse anybody."


Whether his televised confession will help or hurt Armstrong's bruised reputation and his already-tenuous defense in at least two pending lawsuits, and possibly a third, remains to be seen. Either way, a story that seemed too good to be true — cancer survivor returns to win one of sport's most grueling events seven times in a row — was revealed to be just that.


"This story was so perfect for so long. It's this myth, this perfect story, and it wasn't true," he said.


Winfrey got right to the point when the interview began, asking for yes-or-no answers to five questions.


Did Armstrong take banned substances? "Yes."


Did that include the blood-booster EPO? "Yes."


Did he do blood doping and use transfusions? "Yes."


Did he use testosterone, cortisone and human growth hormone? "Yes."


Did he take banned substances or blood dope in all his Tour wins? "Yes."


In his climb to the top, Armstrong cast aside teammates who questioned his tactics, yet swore he raced clean and tried to silence anyone who said otherwise. Ruthless and rich enough to settle any score, no place seemed beyond his reach — courtrooms, the court of public opinion, even along the roads of his sport's most prestigious race.


That relentless pursuit was one of the things that Armstrong said he regretted most.


"I deserve this," he said twice.


"It's a major flaw, and it's a guy who expected to get whatever he wanted and to control every outcome. And it's inexcusable. And when I say there are people who will hear this and never forgive me, I understand that. I do. ...


"That defiance, that attitude, that arrogance, you cannot deny it."


Armstrong said he started doping in mid-1990s but didn't when he finished third in his comeback attempt.


Anti-doping officials have said nothing short of a confession under oath — "not talking to a talk-show host," is how World Anti-Doping Agency director general David Howman put it — could prompt a reconsideration of Armstrong's lifetime ban from sanctioned events.


He's also had discussions with officials at the U.S. Anti-Doping Agency, whose 1,000-page report in October included testimony from nearly a dozen former teammates and led to stripping Armstrong of his Tour titles. Shortly after, he lost nearly all his endorsements, was forced to walk away from the Livestrong cancer charity he founded in 1997, and just this week was stripped of his bronze medal from the 2000 Olympics.


Armstrong could provide information that might get his ban reduced to eight years. By then, he would be 49. He returned to triathlons, where he began his professional career as a teenager, after retiring from cycling in 2011, and has told people he's desperate to get back.


Initial reaction from anti-doping officials ranged from hostile to cool.


WADA president John Fahey derided Armstrong's defense that he doped to create "a level playing field" as "a convenient way of justifying what he did — a fraud."


"He was wrong, he cheated and there was no excuse for what he did," Fahey said by telephone in Australia.


If Armstrong "was looking for redemption," Fahey added, "he didn't succeed in getting that."


USADA chief Travis Tygart, who pursued the case against Armstrong when others had stopped, said the cyclist's confession was just a start.


"Tonight, Lance Armstrong finally acknowledged that his cycling career was built on a powerful combination of doping and deceit," Tygart said. "His admission that he doped throughout his career is a small step in the right direction. But if he is sincere in his desire to correct his past mistakes, he will testify under oath about the full extent of his doping activities."


Livestrong issued a statement that said the charity was "disappointed by the news that Lance Armstrong misled people during and after his cycling career, including us."


"Earlier this week, Lance apologized to our staff and we accepted his apology in order to move on and chart a strong, independent course," it said.


The interview revealed very few details about Armstrong's performance-enhancing regimen that would surprise anti-doping officials.


What he called "my cocktail" contained the steroid testosterone and the blood-booster erythropoetein, or EPO, "but not a lot," Armstrong said. That was on top of blood-doping, which involved removing his own blood and weeks later re-injecting it into his system.


All of it was designed to build strength and endurance, but it became so routine that Armstrong described it as "like saying we have to have air in our tires or water in our bottles."


"That was, in my view, part of the job," he said.


Armstrong was evasive, or begged off entirely, when Winfrey tried to connect his use to others who aided or abetted the performance-enhancing scheme on the USPS team


When she asked him about Italian doctor Michele Ferrari, who was implicated in doping-related scrapes and has also been banned from cycling for life, Armstrong replied, "It's hard to talk about some of these things and not mention names. There are people in this story, they're good people and we've all made mistakes ... they're not monsters, not toxic and not evil, and I viewed Michele Ferrari as a good man and smart man and still do."


But that's nearly all Armstrong would say about the physician that some reports have suggested educated the cyclist about doping and looked after other aspects of his training program.


He was almost as reluctant to discuss claims by former teammates Tyler Hamilton and Floyd Landis that Armstrong told them, separately, that he tested positive during the 2001 Tour de Suisse and conspired with officials of the International Cycling Union officials to cover it up — in exchange for a donation.


"That story wasn't true. There was no positive test, no paying off of the labs. There was no secret meeting with the lab director," he said.


Winfrey pressed him again, asking if the money he donated wasn't part of a tit-for-tat agreement, "Why make it?"


"Because they asked me to," Armstrong began.


"This is impossible for me to answer and have anybody believe it," he said. "It was not in exchange for any cover-up. ... I have every incentive here to tell you yes."


Finally, he summed up the entire episode this way: "I was retired. ... They needed money."


Ultimately, though, it was Landis who did the most damage to Armstrong's story. Landis was stripped of the 2006 Tour title after testing positive and wound up on the sport's fringes looking for work. Armstrong said his former teammate threatened to release potentially destructive videos if he wasn't given a spot on the team. That was in 2009, when Armstrong returned to the Tour after four years off.


Winfrey asked whether Landis' decision to talk was "the tipping point."


"I'd agree with that. I might back it up a little and talk about the comeback. I think the comeback didn't sit well with Floyd," Armstrong recalled.


"Do you regret now coming back?"


"I do. We wouldn't be sitting here if I didn't come back," he said.


The closest Armstrong came to contrition was when Winfrey asked him about his apologies in recent days, notably to former teammate Frankie Andreu, who struggled to find work in cycling after Armstrong dropped him from the USPS team, as well as his wife, Betsy. Armstrong said she was jealous of his success, and invented stories about his doping as part of a long-running vendetta.


"Have you made peace?" Winfrey asked.


"No," Armstrong replied, "because they've been hurt too badly, and a 40-minute (phone) conversation isn't enough."


He also called London Sunday Times reporter David Walsh as well as Emma O'Reilly, who worked as a masseuse for the USPS team and later provided considerable material for a critical book Walsh wrote about Armstrong and his role in cycling's doping culture.


Armstrong subsequently sued for libel in Britain and won a $500,000 judgment against the newspaper, which is now suing to get the money back. Armstrong was, if anything, even more vicious in the way he went after O'Reilly. He intimated she was let go from the Postal team because she seemed more interested in personal relationships than professional ones.


"What do you want to say about Emma O'Reilly?" Winfrey asked.


"She, she's one of these people that I have to apologize to. She's one of these people that got run over, got bullied."


"You sued her?"


"To be honest, Oprah, we sued so many people I don't even," Armstrong said, then paused, "I'm sure we did."


Near the end of the first interview installment, Winfrey asked about a federal investigation of Armstrong that was dropped by the Justice Department without charges.


"When they dropped the case, did you think: 'Now, finally over, done, victory'?"


Armstrong looked up. He exhaled.


"It's hard to define victory," he said. "But I thought I was out of the woods."


___


AP Sports Writers Jim Vertuno in Austin, Texas, Eddie Pells in Denver and Dennis Passa in Melbourne contributed to this report.


Read More..